RecruitingNot ApplicableNCT07081698

Walnuts as an Infant Solid Food for Health

Walnut as a First Food During Complementary Feeding on Gut Microbiota and Immunity Development in Breastfed Infants


Sponsor

Colorado State University

Enrollment

90 participants

Start Date

May 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The objective is to investigate the effect of walnuts on gut microbiota, inflammatory markers, atopic dermatitis status, and indices of allergy outcomes in breastfed infants during early complementary feeding. The three primary aims include: Aim 1: Evaluate the effect of walnut consumption on gut microbiota structure and function, inflammation, atopic dermatitis, and allergy outcomes. Aim 2: Evaluate the impact of walnut consumption on infant growth trajectories and risk of overweight. Aim 3 (exploratory): Identify walnut-specific food signatures that are associated with gut microbiota and immunity biomarkers using a novel nutri-metabolomics technique.


Eligibility

Min Age: 5 MonthsMax Age: 5 Months

Inclusion Criteria4

  • Full term: gestational age ≥ 37 weeks
  • Generally healthy without conditions that would affect normal growth
  • No significant consumption of complementary food (e.g., no more than 1 oz of solid foods per week)
  • Exclusively breastfed (< 2 weeks of cumulative formula exposure)

Exclusion Criteria3

  • Adults unable to consent
  • Pregnant women
  • Prisoners

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERInfant walnut intake

The intervention group will receive walnuts at 10 g/day, and the control group will be advised to avoid walnuts/tree nuts during the intervention. The purpose of this research is to learn more about how walnuts as a first food in infants impact immunity and the development of bacteria living in your baby's gut.


Locations(1)

Food Science and Human Nutrition Clinical Research Laboratory

Fort Collins, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07081698


Related Trials